The LGI1/ADAM23 (ligand-receptor) complex is considered “an exciting therapeutic target for human epilepsy” [50] and the same can be stated about BRUNOL4, since alterations in this gene are involved not only in epilepsy but also in other neurological conditions, such as autism [47]. This evidence concerns the gene ADAM23 and autism.